Insulin aspart, recombinant Subcutaneous and Ixekizumab Auto-Injectors
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Ixekizumab Auto-Injectors and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: ixekizumab
Brand name: Taltz Autoinjector, Taltz Prefilled Syringe
Synonyms: Ixekizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Ixekizumab Prefilled Syringes
- Insulin aspart, recombinant Subcutaneous-Ixekizumab Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Ixempra
- Insulin aspart, recombinant Subcutaneous-Ixempra Kit
- Insulin aspart, recombinant Subcutaneous-Ixiaro
- Insulin aspart, recombinant Subcutaneous-Ixifi Intravenous
- Ixekizumab Auto-Injectors-Insulin degludec
- Ixekizumab Auto-Injectors-Insulin Degludec (U-100) Prefilled Pens
- Ixekizumab Auto-Injectors-Insulin Degludec (U-100) Vials
- Ixekizumab Auto-Injectors-Insulin Degludec (U-200) Prefilled Pens
- Ixekizumab Auto-Injectors-Insulin degludec and liraglutide
- Ixekizumab Auto-Injectors-Insulin degludec and liraglutide Subcutaneous